Shelley B Thunen's Net Worth
$7.54 Million
Who is Shelley B Thunen?
Shelley B Thunen has an estimated net worth of $7.54 Million. This is based on reported shares across multiple companies, which include RxSight, Inc., INTRALASE CORP, Restoration Robotics, Inc., AEON Biopharma, Inc., ENDOLOGIX INC /DE/, and LENZ Therapeutics, Inc..
SEC CIK
Shelley B Thunen's CIK is 0001297491
Past Insider Trading and Trends
2024 was Shelley B Thunen's most active year for acquiring shares with 16 total transactions. Shelley B Thunen's most active month to acquire stocks was the month of February. 2024 was Shelley B Thunen's most active year for disposing of shares, totalling 23 transactions. Shelley B Thunen's most active month to dispose stocks was the month of March. 2024 saw Shelley B Thunen paying a total of $1,601,764.24 for 442,615 shares, this is the most they've acquired in one year. In 2007 Shelley B Thunen cashed out on 332,174 shares for a total of $5,413,464.92, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RxSight, Inc. (RXST) Snapshot price: $52.95
See remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 7
| |||
Form 4
| +118.42% | 16.5K |
$4.34 | $71,631.70 | 30.44K |
Jul 15
| |||
Form 4
| -37.61% | -8.40K |
$37.14 | -$923,832.65 | 13.94K |
Jul 1
| |||
Form 4
| +1.80% | 247 |
$34.14 | -$367,076.94 | 13.94K |
May 1
| |||
Form 4
| -70.42% | -20.00K |
$49.90 | -$997,946.23 | 8.4K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
$35.99 | -$407,742.65 | 13.69K |
Mar 1
| |||
Form 4
| +101.61% | 6.9K |
$29.99 | -$778,964.25 | 13.69K |
Feb 5 - Feb 6
| |||
Form 4
| +196.42% | 4.5K |
$30.43 | -$998,054.08 | 6.79K |
Jan 26
| |||
Form 4
|
—
|
0
|
$27.42 | -$236,425.75 | 2.29K |
Jan 2
| |||
Form 4
| -39.45% | -20.00K |
$27.47 | -$1,261,310.00 | 30.69K |
Scheduled
|
Dec 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INTRALASE CORP No price found
EVP & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -89.05K |
$25.00 | -$2,226,150.00 |
0
|
Apr 2
| |||
Form 4
| +82.58% | 14.72K |
$1.44 | $21,218.85 | 32.55K |
Mar 29
| |||
Form 4
| +1,208.88% | 16.46K |
$13.37 | $24.83 | 17.83K |
Mar 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 28
| |||
Form 4
| -100.00% | -8.38K |
$20.29 | -$169,951.38 |
0
|
Scheduled
|
Mar 22
| ||
Form 4
| -10.66% | -1.00K |
$19.35 | -$19,353.00 | 8.38K |
Scheduled
|
Feb 22
| ||
Form 4
| -79.38% | -36.10K |
$19.08 | -$688,638.71 | 9.38K |
Scheduled
|
Feb 22
| ||
Form 4
| -19.33% | -10.90K |
$18.64 | -$203,174.94 | 45.48K |
Scheduled
|
Feb 22
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Restoration Robotics, Inc. (VERO) Snapshot price: $0.53
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AEON Biopharma, Inc. (AEON) Snapshot price: $0.752
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 36.02K |
—
|
—
| 36.02K |
Aug 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ENDOLOGIX INC /DE/ No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -68.25% | -36.85K |
—
|
—
| 17.14K |
Oct 19
| |||
Form 4
| +3.02% | 1.58K |
$16.45 | -$15,693.30 | 53.99K |
May 22
| |||
Form 4
| +4.07% | 2.15K |
$15.77 | -$26,383.21 | 54.95K |
Feb 27
| |||
Form 4
| +40.37% | 15.19K |
—
|
—
| 52.8K |
May 22
| |||
Form 4
|
∞
| 37.62K |
$13.85 | -$33,018.40 | 37.62K |
Jan 2 - Mar 11
| |||
Form 4
|
∞
| 40K |
—
|
—
| 40K |
Jan 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||